Example: Heart Attack

Clinical Trials on Glabellar Crease

Total 10000 results

NCT05665660

Completed

Developing and Evaluating Culturally Relevant Interventions to Improve Breast Cancer Screening

Breast Cancer
NCT02050750

Active, not recruiting

TAILORx Tissue Bank

Breast Cancer
NCT05114720

Completed

Moxifloxacin in Adjuvant Treatment of Patients With Operable Breast Cancer

Breast Cancer
NCT04534010

Terminated

Decellularized, Whole Donor Nipple-Areola Complex Reconstruction Grafts

Breast Cancer
NCT04532177

Active, not recruiting

Stereotactic Body Radiation Therapy (SBRT) for Invasive Breast Cancer Patients Not Undergoing Definitive Surgery (SBRT BREAST)

Breast Cancer
NCT06851442

Terminated

Clinical Trial of Evaluating TQB3912 Tablets Combined With Fulvestrant Injection±TQB3616 Capsules for Locally Advanced or Metastatic Hormone Receptor(HR)-Positive and Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Cancer

Breast Cancer
NCT06219434

Completed

Evaluation of a Mindfulness Intervention to Prevent Chemo-brain in Women Preparing for Chemotherapy for Breast Cancer

Breast Carcinoma
NCT04661982

Active, not recruiting

Long Term Follow-Up in Patients With Stage 0-IIIC Breast Cancer

Breast Cancer
NCT03657628

Active, not recruiting

Physical Activity, Proliferation and Immune Markers in Benign Breast Tissue

Breast Cancer
NCT05266105

Active, not recruiting

A Phase 1 Study of Oral OP-1250 in Combination With Palbociclib in HR+/HER2- Breast Cancer Patients

Breast Cancer
NCT04514419

Active, not recruiting

Treatment of Breast Cancer With Trastuzumab + HS627/ Pertuzumab + Docetaxel

Breast Cancer
NCT05950685

Completed

Prediction of Long-term Arm Morbidity Following Breast Cancer Surgeries and Treatments

Breast Cancer
NCT04647487

Completed

A Study of LY3484356 in Women With Breast Cancer Before Having Surgery (EMBER-2)

Breast Cancer
NCT06133348

Completed

Promoting Resilience in Women With Breast Cancer (PRISM)

Breast Cancer
NCT01472094

Active, not recruiting

The Hurria Older PatiEnts (HOPE) With Breast Cancer Study

Breast Cancer
NCT03927768

Active, not recruiting

Abbreviated Breast MRI (AB-MRI) With Golden-angle Radial Compressed-sensing and Parallel Imaging (GRASP)

Breast Cancer
NCT01203839

Active, not recruiting

Partial Breast Irradiation (PBI) Using 40 Gy for Select Patients With Early Invasive or Noninvasive Breast Cancer

Breast Cancer
NCT01754597

Completed

Natriuretic Peptide Concentrations of B-type (BNP) During Anesthesia in Patients Previously Sensitized to Anthracyclines (PEP-NAT-B)

Breast Cancer
NCT00989638

Active, not recruiting

A Multi Modality Surveillance Program for Women At High Risk for Breast Cancer

Breast Cancer
NCT02562118

Active, not recruiting

Neoadjuvant Lenvatinib Combined With Letrozole in Hormone Receptor Positive Breast Cancer

Breast Cancer
NCT04292847

Completed

LCCC1931:Post-treatment Intervention in Women With Breast Cancer (70y/o+)

Breast Cancer
NCT04040569

Active, not recruiting

A Phase I Dose Escalation Study of Single Fraction Pre-operative Partial Breast (S-PBI) for Early Stage Breast Cancer

Breast Cancer
NCT05128773

Terminated

Study of Amcenestrant (SAR439859) Versus Tamoxifen for Patients With Hormone Receptor-positive (HR+) Early Breast Cancer, Who Have Discontinued Adjuvant Aromatase Inhibitor Therapy Due to Treatment-related Toxicity (AMEERA-6)

Breast Cancer
NCT04478266

Terminated

Amcenestrant (SAR439859) Plus Palbociclib as First Line Therapy for Patients With ER (+) HER2(-) Advanced Breast Cancer (AMEERA-5)

Breast Cancer
NCT03585621

Active, not recruiting

Stereotactic Body Radiation Therapy for Breast Cancer

Breast Cancer
NCT01182506

Active, not recruiting

Rehabilitation of Cognitive Changes in Breast Cancer Survivors

Breast Cancer
NCT03093350

Completed

TACTIC - TAA Specific Cytotoxic T Lymphocytes in Patients With Breast Cancer (TACTIC)

Breast Cancer
NCT05634395

Active, not recruiting

Digital Phenotyping in Women Over 70 Years of Age Treated for Breast Cancer With Any Type of Treatment (GrannyFit)

Breast Cancer
NCT05258539

Active, not recruiting

Breast Cancer Prevention and Screening Membership (AdDePi_KS)

Breast Cancer
NCT06198751

Active, not recruiting

A Study of Neoadjuvant Treatment With TQB2102 for Injection for Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer

Breast Cancer
NCT01290835

Completed

Conformal Partial Breast Irradiation With CyberKnife After Resection for Early Stage Breast Cancer (CKPBI)

Breast Cancer
NCT05560685

Terminated

SMART-ER: Symptom Monitoring With Patient-reported Outcomes (SMART-ER)

Breast Cancer
NCT03858322

Active, not recruiting

'ADVANCE' (A Pilot Trial)

Breast Cancer
NCT04388384

Completed

Real-life Pan-HER-blockade With Neratinib (ELEANOR)

Breast Neoplasm
NCT05802225

Active, not recruiting

Clinical Study of the Efficacy and Safety of BCD-178 and Perjeta® as Neoadjuvant Therapy of HER2-Positive Breast Cancer (PREFER)

Breast Cancer
NCT07072013

Completed

An Indirect Treatment Comparison of the Effectiveness of Ribociclib Combined With Non-steroidal Aromatase Inhibitors vs. Tamoxifen for the Adjuvant Treatment of Premenopausal Women With Hormon Receptor-positive, HER2-negative Early Breast Cancer (IRINA)

Breast Cancer
NCT03725059

Active, not recruiting

Study of Pembrolizumab (MK-3475) Versus Placebo in Combination With Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer (MK-3475-756/KEYNOTE-756)

Breast Cancer
NCT03414658

Active, not recruiting

The AVIATOR Study: Trastuzumab and Vinorelbine With Avelumab OR Avelumab & Utomilumab in Advanced HER2+ Breast Cancer

Breast Cancer
NCT03831178

Active, not recruiting

Docosahexaenoic Acid (DHA) for Women With Breast Cancer in the Neoadjuvant Setting (DHA-WIN)

Breast Cancer
NCT03992859

Completed

Continuous Serrates Plane Block in Axillary Dissection

Breast Cancer
NCT00508352

Completed

Post-operative Radiation With IMRT in the Management of Stage IIB-III Breast Cancer

Breast Cancer
NCT05902507

Suspended

Magnetic Resonance Imaging in Radiotherapy for Breast Cancer (MIRROR)

Breast Cancer
NCT05498155

Active, not recruiting

Study of Neoadjuvant Olaparib Monotherapy and Olaparib and Durvalumab Combination in HER2 Negative BRCAm Breast Cancer (OlympiaN)

Breast Cancer
NCT04774471

Completed

Advanced Diffusion Tensor MRI for Breast Cancer

Breast Cancer | Breast Diseases
NCT01441947

Completed

Cabozantinib in Women With Metastatic Hormone-Receptor-Positive Breast Cancer

Breast Cancer
NCT03611543

Completed

Evaluating Image Quality and Comfort of an Investigational Curved Paddle Compared to a Standard Paddle

Breast Cancer
NCT06978478

Withdrawn

An Imaging Study in ER Negative Breast Cancer by Targeting αvβ6 (IMETAB6)

Breast Cancer
NCT06231693

Terminated

Trastuzumab-deruxtecan in Patients With Triple-negative Metastatic HER2-Low Breast Cancer: Real-world Experience in Brazil

Breast Cancer
NCT02040857

Completed

Palbociclib in Combination With Adjuvant Endocrine Therapy for Hormone Receptor Positive, HER2 Negative Invasive Breast Cancer

Breast Cancer
NCT03913936

Completed

Young, Empowered & Strong (YES): The Young Women's Breast Cancer Study 2- Focus on Intervention Pilot

Breast Cancer

Clinical Trials on Glabellar Crease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations